Fractional Exhaled Nitric Oxide Clinical Utility in Asthma Management
Project Summary Title and Description
- Fractional Exhaled Nitric Oxide Clinical Utility in Asthma Management
- To evaluate the clinical utility and diagnostic accuracy of fractional exhaled nitric oxide (FeNO) in people age 5 years and older with asthma; and the ability of FeNO measured at age 4 years or younger to predict a future diagnosis of asthma. PubMed ID:
- Authors of Report
- Methodology description
- We searched from databases’ inception to April 2017 for studies enrolling patients with or suspected to have asthma that evaluated the diagnosis or clinical utility of FeNO. We included randomized and nonrandomized comparative studies.
- Attached Files: Baseline and outcomes.pdf: Baseline characteristics for included studies and outcomes Outcomes.pdf: Diagnostic accuracy of FeNO measurement outcomes Quality.pdf: Quality assessment for included studies
- Funding Source
- 1. What is the clinical utility of FeNO measurements in the management of asthma in addition to, or instead of, other tests that might be performed? KQ 1.a: What is the diagnostic accuracy of FeNO measurement(s) for making the diagnosis of asthma in individuals ages 5 and older? KQ 1.b: What is the clinical utility of FeNO measurements in monitoring disease activity and asthma outcomes in individuals with asthma ages 5 and older ? KQ 1.c: What is the clinical utility of FeNO measurements to select medication options (including steroids) for individuals ages 5 and older? KQ 1.d: What is the clinical utility of FeNO measurements to monitor response to treatment in individuals ages 5 and older? KQ 1.e. In children ages 0-4 years with recurrent wheezing, how accurate is FeNO testing in predicting the future development of asthma at age 5 and above?
Associated Extraction Forms
Associated Studies (each link opens a new tab)
Downloadable Data Content
- XLSX Project Data